The European Medicines
Agency’s Pharmacovigilance Risk
Assessment Committee (PRAC)
has recommended that Protelos/
Osseor should no longer be used to
treat osteoporosis.
The recommendation follows an
in-depth review of the risks and
benefits of the medication showing
that for every 1,000 patient-years
there were 4 more cases of serious
heart problems and 4 more cases
of blood clots or blockages of blood
vessels with Protelos/Osseor than
with placebo.
To see other complications and
further details, CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 13 Jan 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Jan 14
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.